Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: update for publication

Documents 

Timeline


Sept 2022 BallotJan 2023 Ballot
Notice of Intent to Ballot (NIB)July 3 - doneNov 1, 2022
Final Content to Pharmacy WGAug 1 - doneNov 28, 2022
Final Content deadlineAug 7 - doneDec 6, 2022
Ballot openAug 12Dec 11, 2022
  concurrent NCPDP comment-only ballot

Ballot closeSept 11 - doneJan 11, 2023
ReconciliationSept 12 ... in progressDec 1 - done
Pre-pub reviewFeb 26 - done
Submit for publicationpending

Project change to FHIR IG

On the June 2nd Consultant Pharmacist Interoperability call, the group discussed the FHIR IG v Guidance Document issue and decided to stay with a guidance document.  FHIR IG work has been suspended.

During the May 2022 WGM Pharmacy WG Thursday Q2 session, there was considerable discussion on changing the final output to a FHIR IG.  This would retain all of the current content - C-CDA and FHIR.  The primary driver was a FHIR IG is more likely to be visible to FHIR developers - they know to search for FHIR IGs and probably would not consider searching for guidance documents.  

Changing to creating a FHIR IG requires:  

  • change request for PSS
  • request for approval to create a FHIR IG
  • request for HL7 GitHub repository for development of the IG
  • transfer of existing content to the IG
    • establishing the software environment to produce the IG

FHIR IG Process steps/status

taskdate / status

PSS change request to create FHIR IG

  •   

Draft submitted to project team, Pharmacy and StrucDoc  co-chairs for review.

Pharmacy WG approved change

Jira
serverJira
serverId9b965702-34a7-3433-bf10-7f66fd69238c
keyPSS-1884

PSS-1884 Pharmacist Consultation Note FHIR IG.doc

Request to develop FHIR IG

  •   

Draft submitted to project team and pharmacy co-chairs

Pharmacy WG approved IG request

Pharmacist Consultation Note IG

Request GitHub repository

  •   

Jira ticket created.  Needs FHIR IG approval before repository can be created

done

Jira
serverJira
serverId9b965702-34a7-3433-bf10-7f66fd69238c
keyGRR-38

Set up development environment

  •   

started installing components - FSH, SUSHI, FHIR IG publisher, more - 

development environment complete


FSH (FHIR ShortHand) course

  •   

course materials released


Initial port of Guidance Document to FHIR IG

  •   


Project Development

Project Proposal

Project Scope Statement

Jira
serverJira
columnIdsissuekey,summary,issuetype,created,updated,duedate,assignee,reporter,priority,status,resolution
columnskey,summary,type,created,updated,due,assignee,reporter,priority,status,resolution
serverId9b965702-34a7-3433-bf10-7f66fd69238c
keyPSS-1813

Jira
serverJira
columnIdsissuekey,summary,issuetype,created,updated,duedate,assignee,reporter,priority,status,resolution
columnskey,summary,type,created,updated,due,assignee,reporter,priority,status,resolution
serverId9b965702-34a7-3433-bf10-7f66fd69238c
keyPSS-1884

Description

This project will create a joint HL7/NCPDP Consultant Pharmacist Consult Note guidance document. The guidance document will address the use of either CCDA Consult Note or FHIR Consultation Note Profile. This will be a guidance document, not an implementation guide or FHIR profile.

Previously, NCPDP published the NCPDP Consultant Pharmacy Consult Note guidance document to address how CCDA Consult Note is to be used to address Consultant Pharmacy reporting requirements..

This project will update the NCPDP Consultant Pharmacy Consult Note guidance document as described above to address both the C-CDA Consultation Note and the C-CDA on FHIR Consultation Note Profile. The product of this project will be published as a joint NCPDP/HL7 document.

Note: Initial review has not revealed any additional constraints or extensions on the FHIR Consultation Note Profile, thus allowing this project to just produce a guidance document. If constraints or extensions become necessary, then a FHIR profile will be developed and jointly published, following HL7 processes to revise a project.

Description

This project will create a joint HL7/NCPDP Consultant Pharmacist Consult Note guidance document. The guidance document will address the use of either C-CDA Consult Note or C-CDA on FHIR Consultation Note Profile. This will be a guidance document, not an implementation guide or FHIR profile.

Previously, NCPDP published the NCPDP Consultant Pharmacy Consult Note guidance document to address how C-CDA Consult Note is to be used to address Consultant Pharmacy reporting requirements..

This project will update the NCPDP Consultant Pharmacy Consult Note guidance document as described above to address both the C-CDA Consultation Note and the C-CDA on FHIR Consultation Note Profile. The product of this project will be published as a joint NCPDP/HL7 document.

Note: Initial review has not revealed any additional constraints or extensions on the FHIR Consultation Note Profile, thus allowing this project to just produce a guidance document. If constraints or extensions become necessary, then a FHIR profile will be developed and jointly published, following HL7 processes to revise a project.






Project Calls

every other Monday at 1p EST / 10a PST / 1800 UTC 

see the agenda/minute list below for the next session


Web session:  https://zoom.us/j/3231998494
phone: 669-900-6833, meeting 3231998494#
voip/iOS/Android: 
     tel:+16699006833,,3231998494#  US (San Jose CA)
Find your local number: https://us02web.zoom.us/u/kbxHfAjJot
 

Children Display
sorttitle
reversetrue